Term ends Mar 9, 2033 · High confidence
20-year base term ends Mar 9, 2033
Mar 9, 2013
Mar 9, 2033
Dec 10, 2019
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 9, 2013, when application PCT/US2013/030070, the earliest non-provisional in its chain, was filed (this one was filed Feb 6, 2017) | Mar 9, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,385,106, US 10,463,751, US 10,493,167, US 10,501,512) | resolves to Mar 9, 2033, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 9, 2033 | High confidence |
This family
| Application PCT/US2013/030070 | PCT application no patent term | no patent term |
| Application PCT/US2013/030060 | PCT application no patent term | no patent term |
| Application PCT/US2013/030059 | PCT application no patent term | no patent term |
| Application PCT/US2013/030066 | PCT application no patent term | no patent term |
| Application PCT/US2013/030062 | PCT application no patent term | no patent term |
| Application PCT/US2013/030063 | PCT application no patent term | no patent term |
| Application PCT/US2013/030064 | PCT application no patent term | no patent term |
| Application PCT/US2013/030067 | PCT application no patent term | no patent term |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 28, 2018 Reel 45755, frame 844 | Moderna Therapeutics, Inc. | ModernaTX, Inc. | Change of Name |
| Apr 19, 2018 Reel 45592, frame 230 | Bancel, Stephane; Chakraborty, Tirtha; De Fougerolles, Antonin; Whoriskey, Susan | Moderna Therapeutics, Inc. | Assignment of Assignor's Interest |
| Apr 19, 2018 Reel 45592, frame 463 | Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Wood, Kristy M.; Hatala, Paul; Ellsworth, Jeff Lynn; Guild, Justin | Moderna Therapeutics, Inc. | Assignment of Assignor's Interest |
| May 25, 2018 Reel 45902, frame 793 | Ejebe, Kenechi | Moderna Therapeutics, Inc. | Assignment of Assignor's Interest |
| Sep 17, 2018 Reel 47531, frame 685 | Schrum, Jason | ModernaTX, Inc. | Assignment of Assignor's Interest |
| Nov 19, 2025 Reel 73634, frame 354 | ModernaTX, Inc. | Ares Capital Corporation, As Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,385,106, US 10,463,751, US 10,493,167, US 10,501,512, ends no earlier than this term, so it caps nothing.